Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
DoD Breast Cancer, Breakthrough Award Levels 1 and 2
The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer.
The critical components of this award mechanism are:
Impact:
Research supported by the Breakthrough Award will have the potential for a major
impact and accelerate progress toward ending breast cancer.
The impact may be near-term or long-term, but must move beyond a minor advancement and have the potential to lead to a new approach that is fundamentally better than interventions already approved or in clinical development.
Applications are expected to identify the breast cancer patients or at-risk individuals who would ultimately benefit from the proposed research.
Research Scope:
Research proposed under this award mechanism may be small- to large-scale projects, at different stages of idea and research development.
Two different funding levels, based on the scope of the research, are available under this Program Announcement.
This Program Announcement discusses Funding Levels 1 and 2. Funding Levels 3 and 4 are available under a different Program Announcement (W81XWH-18-BCRP-BTA34-2).
When submitting the pre-application, it is the responsibility of the Principal Investigator (PI) to select the funding level that is most appropriate for the research proposed.
The funding level should be selected based on the scope of the research project, rather than the amount of the budget.
The following are general descriptions, although not all-inclusive, of the scope of research projects that would be appropriate to propose under each funding level:
Funding Level 1:
Innovative, high-risk/high-reward research that is in the earliest stages of idea development.
Research with potential to yield new avenues of investigation.
Proof of concept.
No preliminary data required.
Funding Level 2:
Research that is already supported by preliminary data and has potential to make significant advancements toward clinical translation.
Partnering PI Option:
The Breakthrough Award encourages applications that include meaningful and productive collaborations between investigators.
The Partnering PI Option is structured to accommodate two PIs, referred to as the Initiating PI and the Partnering PI, each of whom will be funded with a separate award.
There are different submission requirements for the Initiating and Partnering PIs’ applications; however, both PIs should contribute significantly to the development of the proposed research project including the Project Narrative, Statement of Work (SOW), and other required components.
The PIs may have expertise in similar or disparate scientific disciplines, but each PI is expected to bring distinct contributions to the application.
New collaborations are encouraged, but not required.
The application is expected to describe how the PIs’ combined expertise will better address the research question and explain why the work should be done together rather than through separate efforts.
To meet the intent of the Partnering PI Option, investigators are discouraged from being named as a Partnering PI on multiple Breakthrough Award Levels 1 and 2 applications unless they are clearly addressing distinct research questions.
Applications in which a mentor and his/her current postdoctoral fellow or junior investigator are named as Initiating and Partnering PIs do not meet the intent of the Partnering PI Option.
Personnel:
Applications are expected to include an appropriate and robust research team with the combined backgrounds and breast cancer-related expertise to enable successful conduct of the project.
Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this funding opportunity.
Applications seeking support for a clinical trial may be submitted to the FY18 BCRP Breakthrough Award Levels 3 and 4 Program Announcement (W81XWH-18-BCRP-BTA34-2).
The proposed research must be relevant to active duty Service members, Veterans, military beneficiaries, and/or the American public.
The critical components of this award mechanism are:
Impact:
Research supported by the Breakthrough Award will have the potential for a major
impact and accelerate progress toward ending breast cancer.
The impact may be near-term or long-term, but must move beyond a minor advancement and have the potential to lead to a new approach that is fundamentally better than interventions already approved or in clinical development.
Applications are expected to identify the breast cancer patients or at-risk individuals who would ultimately benefit from the proposed research.
Research Scope:
Research proposed under this award mechanism may be small- to large-scale projects, at different stages of idea and research development.
Two different funding levels, based on the scope of the research, are available under this Program Announcement.
This Program Announcement discusses Funding Levels 1 and 2. Funding Levels 3 and 4 are available under a different Program Announcement (W81XWH-18-BCRP-BTA34-2).
When submitting the pre-application, it is the responsibility of the Principal Investigator (PI) to select the funding level that is most appropriate for the research proposed.
The funding level should be selected based on the scope of the research project, rather than the amount of the budget.
The following are general descriptions, although not all-inclusive, of the scope of research projects that would be appropriate to propose under each funding level:
Funding Level 1:
Innovative, high-risk/high-reward research that is in the earliest stages of idea development.
Research with potential to yield new avenues of investigation.
Proof of concept.
No preliminary data required.
Funding Level 2:
Research that is already supported by preliminary data and has potential to make significant advancements toward clinical translation.
Partnering PI Option:
The Breakthrough Award encourages applications that include meaningful and productive collaborations between investigators.
The Partnering PI Option is structured to accommodate two PIs, referred to as the Initiating PI and the Partnering PI, each of whom will be funded with a separate award.
There are different submission requirements for the Initiating and Partnering PIs’ applications; however, both PIs should contribute significantly to the development of the proposed research project including the Project Narrative, Statement of Work (SOW), and other required components.
The PIs may have expertise in similar or disparate scientific disciplines, but each PI is expected to bring distinct contributions to the application.
New collaborations are encouraged, but not required.
The application is expected to describe how the PIs’ combined expertise will better address the research question and explain why the work should be done together rather than through separate efforts.
To meet the intent of the Partnering PI Option, investigators are discouraged from being named as a Partnering PI on multiple Breakthrough Award Levels 1 and 2 applications unless they are clearly addressing distinct research questions.
Applications in which a mentor and his/her current postdoctoral fellow or junior investigator are named as Initiating and Partnering PIs do not meet the intent of the Partnering PI Option.
Personnel:
Applications are expected to include an appropriate and robust research team with the combined backgrounds and breast cancer-related expertise to enable successful conduct of the project.
Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this funding opportunity.
Applications seeking support for a clinical trial may be submitted to the FY18 BCRP Breakthrough Award Levels 3 and 4 Program Announcement (W81XWH-18-BCRP-BTA34-2).
The proposed research must be relevant to active duty Service members, Veterans, military beneficiaries, and/or the American public.
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
https://www.grants.gov
Additional Information of Eligibility:
This is a limited competition, under which only local and regional (indigenous) organizations, large or small commercial (for profit) firms, faith-based, and non-profit organizations in partnerships or consortia, from Uganda and East African Region, are eligible to compete.
Full Opportunity Web Address:
https://www.grants.gov
Contact:
Agency Email Description:
CDMRP Help Desk
Agency Email:
Date Posted:
2018-07-17
Application Due Date:
Archive Date:
2018-12-15
Social Entrepreneurship
Spotlight
Hugh Jackman: Fair Trade Entrepreneur
Renowned actor, Hugh Jackman, talks about how he started becoming a fair trade entrepreneur. Jackman is constantly building up ideas and solutions to help small coffee growers get good prices outside the massive coffee industry. His business, Laughing Man Worldwide, reinvests 100% of its profits in its partnerships with farmers.
Learn How to Identify and Avoid Grant Scams
